5-meo-dmt EVENTS

featured by five


About the Events

F.I.V.E. (5-MeO-DMT Information and Vital Education) is proud to announce a series of free monthly webinars. We will be hosting various speakers from the 5-MeO space on different topics ranging from the clinical to the mystical.

At F.I.V.E. we are committed to continual growth and evolution, therefore we aim to bring education of the highest caliber from the top minds in the field. There are many views, philosophies, and differentiating qualities within the context of 5-MeO-DMT, and we would like to approach them as unique parts of the whole. Safety and efficacy will always be first and foremost, and from there we can all grow together.

Come join us as we all continue to learn together. To ensure your seat, please make sure to register and claim your ticket before the event begins. We look forward to seeing you all there!

Upcoming Webinars

F.I.V.E. (5-MeO-DMT Information and Vital Education) is happy to announce the first in a series of free monthly webinars. We will be joined by world renowned psychedelic researcher and TV personality Hamilton Morris who will be discussing the common misconceptions that are prevalent around 5-MeO-DMT. The presentation will be followed by a Q&A segment where attendees can ask questions and engage in conversation. Come join us for a special night of community and learning, we’re excited to see you all!

 

Come join F.I.V.E. along with Ian Benuis for an exciting evening discussing the new psychedelic compound Psilomethoxin.

Psilomethoxin is effectively oral route of administration 5-meo-dmt without any risk of bufotenine poisoning since the molecule does not break down in to the active metabolite 5-oh-dmt (bufotenine) like 5-meo-dmt does.  Also there is no hallucinogenic effect like the classic 5ht2a receptor site substances dmt, psilocin and lsd.  Lastly the slower and smoother onset of psilomethoxin means that the rapid ego dissolution that can occur on 5-meo-dmt is not a factor and the dosing can remain functional and therapeutic at the same time. Psilomethoxin had never been bioassayed until now, thanks to Ian Benouis.